Prometheus, a physical AI startup backed by Jeff Bezos, has raised $12 billion in new funding. The financing round values the company at $41 billion, making it one of the most highly valued private artificial intelligence companies in the world. The startup aims to automate heavy engineering tasks and drug design using advanced AI systems.
The company describes its goal as building an artificial general engineer for the physical world. This represents an ambitious effort to create AI that can handle complex engineering challenges across multiple domains, from infrastructure projects to pharmaceutical development. The funding reflects growing investor interest in AI applications that extend beyond software into manufacturing, construction, and scientific research.
Prometheus joins a wave of well-funded AI startups targeting physical industries. The company's focus on automation in heavy engineering and drug design positions it at the intersection of artificial intelligence and fields that have traditionally relied on human expertise and physical experimentation. Drug design in particular has seen increased AI investment as companies seek to accelerate the discovery and development of new medications.
The $41 billion valuation places Prometheus among the most valuable private technology companies. The substantial funding round signals investor confidence in the potential for AI to transform industries that involve physical products and processes. Jeff Bezos, who founded Amazon and owns aerospace company Blue Origin, has become an active investor in advanced technology companies since stepping down as Amazon's CEO.
The capital will likely support Prometheus's research and development efforts as it works to build AI systems capable of handling the complexity of physical engineering projects. The company faces the challenge of creating AI that can not only process information but also understand the physical constraints and requirements of real-world engineering and scientific work.